TGM2 is increased within the perinecrotic zone of GBM and promotes mesenchymal (MES) trans-differentiation in GSCs by controlling master transcription factors (TF) involving C/EBPβ, TAZ, and STAT3. Here, TGM2 is linked to glioblastoma.